0001209191-19-005380.txt : 20190125 0001209191-19-005380.hdr.sgml : 20190125 20190125165417 ACCESSION NUMBER: 0001209191-19-005380 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190123 FILED AS OF DATE: 20190125 DATE AS OF CHANGE: 20190125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Scheer David CENTRAL INDEX KEY: 0001378585 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33095 FILM NUMBER: 19543083 MAIL ADDRESS: STREET 1: ACHILLION PHARMACEUTICALS STREET 2: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACHILLION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070336 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 BUSINESS PHONE: 203-624-7000 MAIL ADDRESS: STREET 1: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-01-23 0 0001070336 ACHILLION PHARMACEUTICALS INC ACHN 0001378585 Scheer David C/O ACHILLION PHARMACEUTICALS, INC. 300 GEORGE STREET NEW HAVEN CT 06511 1 0 0 0 Stock Option (Right to buy) 2.18 2019-01-23 4 A 0 42000 0.00 A 2029-01-23 Common Stock 42000 42000 D This option vests and becomes exercisable in equal quarterly installments over the one-year period following the date of grant. /s/ Keri Lantz, attorney-in-fact 2019-01-25